Evaluatio<i>N</i> of <i>A</i>pi<i>X</i>aban in str<i>O</i>ke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice <i>S</i>etting in France, rationale and design of the NAXOS: SNIIRAM study
Clinical cardiology